FilingReader Intelligence
China Resources Shuanghe establishes 500m yuan bio-pharmaceutical fund
August 12, 2025 at 09:33 AM UTC•By FilingReader AI
China Resources Shuanghe Pharmaceutical plans to establish a biomedical industry fund targeting 500 million yuan in fundraising. The company and its subsidiary will contribute up to 87 million yuan, representing 17.40% of total capital, to expand its synthetic biology operations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600062•Shanghai Stock Exchange
News Alerts
Get instant email alerts when China Resources Double Crane Pharmaceutical publishes news
Free account required • Unsubscribe anytime